Meiji Milk Products Company, Limited

Meiji Dairies Corporation

Davisco Foods International, Inc.

Tamotsu Kuwata

Tetsuo Kaneko

Yoshiro Yamamoto

Tadashi Kojima

Kaoru Koide

Hideo Ohtomo

Takashi Fukushima

Yukiko Ishiguro

Yuka Nozaki

Martin E Davis

Toshitaka Kobayashi

Yutaka Suginaka

Masako Yajima

Takao Tomita

Isamu Narabayashi

Makiko Nakayama

Osamu Fujita

Kumiko Hiraishi

Kikuhei Tateno

Hideo Hasegawa

Yumi Tsukamoto

Mark Mitchell Davis

Tadashi Nakatsubo

Yoshinori Komatsu

Fumio Miyazawa

Takaji Yajima

Koki Itoyama

The present invention provides agents for alleviating symptoms resulting from inflammation, which have an activity to alleviate inflammatory symptoms caused by bacterial infection, particularly accumulation of body fluid such as bronchocavemous plasma exudation, ascites, etc., at the inflammatory site, or excessive increase of blood neutrophils; symptoms resulting from inflammation caused by bacterial infection, particularly accumulation of body fluid such as bronchocavemous plasma exudation ascites, etc., at the inflammatory site, or excessive increase of blood neutrophils, can be alleviated effectively by ingesting or administering orally or parenterally a composition containing human-type lactoferrin as an effective component.

Agents for alleviating symptoms accompanied by inflammation

A method for inducing immunological tolerance in mammals which comprises feeding an antigen to a mammal, wherein the mammal is not allowed to ingest a fat-soluble component or a fat-soluble component-containing substance simultaneous with ingestion of the antigen, and an immunological tolerance inducing food kit and an immunological tolerance inducer kit which comprise an antigen-containing preparation containing no fat-soluble component and an antigen-free preparation containing no fat-soluble component. According to this invention, immunological tolerance can be induced effectively.

Immunological tolerance inducer kit

A method for inducing immunological tolerance in mammals which comprises feeding an immunogen to a mammal, wherein the mammal is not allowed to ingest a fat-soluble component or a fat-soluble component-containing substance simultaneous with ingestion of the immunogen, and an immunological tolerance including food kit and an immunological tolerance inducer kit which comprises an immunogen-containing preparation containing no fat-soluble component and an immunogen-free preparation containing no fat-soluble component. According to this invention, immunological tolerance can be induced effectively.

Method for inducing immunological tolerance, immunological tolerance

Fabricated rice containing whey protein in the range of 0.1-10% by weight, and optionally sodium alginate and calcium, and a process for preparing the same by mixing starches, whey protein(s), and optionally sodium alginate and a calcium salt with water, followed by heating and shaping.

Fabricated rice

A process for producing a calcium-supplemented milk drink, by adding to cow's milk, a whey mineral being of a calcium content of 2 to 8% by weight and produced by removing the protein and lactose from whey and concentrating the resulting whey by ultrafiltration and/or microfiltration. By the process, there is produced a calcium-supplemented milk drink having good flavor with no precipitate of calcium salts or being provided with attractive flavor, and being capable of passing through the sterilization process to be prepared into a commercially aseptic state.

Process of producing calcium-supplemented milk drinks

A contrasting composition for gastrointestinal tract MRI which contains a trace amount of unchelated manganese is disclosed. The composition has a marked contrasting effect in MRI without causing harm to a living body.

Unchelated manganese composition for MRI of the gastrointestinal tract

The present invention provides formulated milk compositions for infants analogous to human milk in which non-protein nitrogen components are abundant and the contents of .beta.-lactoglobulin and/or .alpha..sub.S casein are reduced.

Method for producing a formulated milk for infants analogous to human

This invention relates to a method of selectively degrading .beta.-lactoglobulin contained in cow's milk-serum protein by using a specific enzyme capable of selectively degrading .beta.-lactoglobulin.

Selective enzymatic degradation of .beta.-lactoglobulin contained in

The present invention relates to a method for separating and concentrating acidic peptide, especially phosphopeptide having a phosphoserine residue, from a peptide mixture prepared by digesting casein with protease.

Method for separation and concentration of phosphopeptides

There is described a method for removing .beta.-lactoglobulin from bovine milk whey, in which bovine milk whey having been demineralized by 60 to 90% by weight is treated so as to have a pH value of from 4.3 to 4.6 and a protein concentration of from 0.5 to 1.5% by weight, and is then brought into contact with a cation exchange cellulose.

Method for removing .beta.-lactoglobulin from bovine milk whey

A method of producing an aseptic calcium-enriched soy bean curd is disclosed. The method includes the steps of adding a calcium hydroxide-sucrose complex as coagulant to the soy bean milk, sterilizing the resulting mixture by heating, adjusting the pH value of the sterilized product to weakly acidic, charging the sterilized product into a container under an aseptic condition and sealing the opening of the container, and coagulating the calcium hydroxide-sucrose complex as coagulant to the soy bean milk by heating. When the calcium hydroxide-sucrose complex used as coagulant is insufficient to provide the required extent of calcium enrichment, calcium lactate may be added in an aseptic atmosphere after the sterilization process as at the time of pH adjustment.

Growing community of inventors

Saitama, Japan

Tamotsu Kuwata